Skip to main content

Table 2 Baseline parameters showing transition probabilities associated with BPH treatment

From: A cost effective analysis of fixed-dose combination of dutasteride and tamsulosin compared with dutasteride monotherapy for benign prostatic hyperplasia in Nigeria: a middle income perspective; using an interactive Markov model

Transitions (from-to)

Average annual probability

Min, max

Dutasteride therapy

Combination therapy

Health to mild BPH

0.29

0.29

Mild BPH to moderate BPH

0.29

0.29

Moderate to severe BPH

0.16

0.058

Moderate/severe to AUR

0.13

0.04

Moderate/severe to TURP

0.16

0.056

TURP to repeat TURP

0.48

0.48

Severe to moderate BPH

0.46

0.49

Moderate to mild BPH

0.46

0.49

Death rate

0.013

0.013